Clinical Trials Browser

INDUSTRY × Interventional × fostamatinib × Clear all

NCT02077192 2023-12-11

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Phase 3 Completed

123 enrolled 11 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT02076399 2019-02-12

FIT

Phase 3 Completed

76 enrolled 17 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT02076412 2019-01-25

FIT

Phase 3 Completed

74 enrolled 17 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT00446095 2016-09-19

Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma

Phase 1/2 Completed

81 enrolled 14 charts

Lymphoma, Lymphoma, Follicular, Lymphoma, Mantle-Cell

NCT00798096 2016-09-19

Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma

Phase 2 Completed

18 enrolled 8 charts

Lymphoma, Lymphoma, T-Cell

NCT01499303 2014-08-22

Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer

Phase 2 Completed

101 enrolled 7 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse